Exact Sciences
EXAS
#1542
Rank
$10.99 B
Marketcap
$59.40
Share price
5.86%
Change (1 day)
-19.19%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -$0.2 Billion USD

According to Exact Sciences's latest financial reports the company's current earnings are $2.69 Billion USD. In 2023 the company made an earning of -$0.19 Billion USD, an increase over its 2022 earnings that were of -$0.62 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.2 Billion0.96%
2023 -$0.19 Billion-69.28%
2022 -$0.62 Billion-25.55%
2021 -$0.83 Billion1.68%
2020 -$0.82 Billion271.17%
2019 -$0.22 Billion58.99%
2018 -$0.14 Billion20.89%
2017 -$0.12 Billion-30.95%
2016 -$0.17 Billion5.09%
2015 -$0.16 Billion57.24%
2014 -$0.11 Billion116.53%
2013 -$46.3 Million
2011 -$28.83 Million143.73%
2010 -$11.83 Million27.85%
2009 -$9.25 Million0.27%
2008 -$9.23 Million-20.95%
2007 -$11.67 Million-13.53%
2006 -$13.5 Million-10.07%
2005 -$15.01 Million-21.81%
2004 -$19.2 Million-33.44%
2003 -$28.84 Million-6.51%
2002 -$30.85 Million17.95%
2001 -$26.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.12 Billion-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$65.88 M-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.17 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-$34.97 Million-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.40 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France